New cystic fibrosis drug is major breakthrough for patients – News – B…
Medical breakthroughs never come easy. But, when they occur, the excitement they generate is extra special. One of the biggest medical breakthroughs of 2019 took place in late October when the Food and Drug Administration approved a new drug (Trikafta) that will benefit 90% of cystic fibrosis patients – those with the most common mutation (delta-F508) to the CFTR gene. “You can’t believe the buzz it created at the national CF meeting in Nashville,” said Peter J. Murphy, M.D, associate professor,…